Back to results
US 11,447,454 B2Granted
Synthesis of benzodiazepine derivatives
AssigneeTrio Medicines Ltd
InventorsMalcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
Life of this patent
Estimating the term…
Abstract
The invention relates to processes for the synthesis of benzodiazepine derivatives of Formula I:
Claims32
A process for producing a compound of formula (I):
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is:
- (i) —CH2C(O)C(R2)(R3)—L—R4 or —CH2CHOHC(R2)(R3)—L—R4, in which:
- R2 and R3 are each, independently, H or C1-3 aliphatic, halo, or C1-3 haloaliphatic, or wherein R2 and R3 together with the intervening carbon atom to which they are bonded, form a C3-6 carbocyclic moiety;
- L is a bond or C1-3 alkylene;
- and
- R4 is —OR5 or —SR5, wherein R5 is hydrogen, optionally substituted alkyl, a protecting group or —C(O)R6, wherein R6 is optionally substituted aliphatic, heteroaliphatic, aromatic or heteroaromatic moiety;
- or
- (ii) —CH2CHOH(CH2)aR7 or —CH2C(O)(CH2)aR8 in which a is 0 or 1 and R7 and R8 are selected from alkyl, cycloalkyl groups and saturated heterocyclic groups optionally substituted at a hetero-atom;
- W and X are, independently, hydrogen, halo, C1-8 alkyl or C1-8 alkoxy;
- and
- rings A and B are each, independently, a monocyclic aryl or heteroaryl, optionally substituted with one or more substituents independently selected from halo, hydroxy, amino, nitro, carboxyl, carboxamido, cyano, —SO3H, and optionally substituted C1-8 alkyl, C1-8 alkoxy, C1-8 alkylamino or di(C1-8 alkyl)amino,
- wherein any one or more substituent on R1, ring A or ring B may be unprotected or in a protected form;
- wherein the process comprises:
- providing a reaction mixture by adding a compound of formula (I-A), a compound of formula (I-B) and a phosgene synthetic equivalent or phosgene to an aprotic solvent, to form a compound of formula (I)
- wherein the phosgene synthetic equivalent is carbonyldiimidazole (CDI), diphosgene, triphosgene, a chloroformate or disuccinimidyl carbonate;
- and
- wherein the reaction is maintained at a temperature of no more than 30° C. and the reaction is carried out in the absence of a base.
15 more elements
A process for producing a compound of formula (I):
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is an optionally substituted aliphatic moiety;
- W and X are, independently, hydrogen, halo, C1-8 alkyl or C1-8 alkoxy;
- and
- rings A and B are each, independently, a monocyclic aryl or heteroaryl, optionally substituted with one or more substituents independently selected from halo, hydroxy, amino, nitro, carboxyl, carboxamido, cyano, —SO3H, optionally substituted C1-8 alkyl, C1-8 alkoxy, C1-8 alkylamino and di(C1-8 alkyl)amino,
- wherein any one or more substituent on R1, ring A or ring B may be unprotected or in a protected form;
- wherein the process comprises:
- providing a reaction mixture by adding a compound of formula (I-A), a compound of formula (I-B) and a phosgene synthetic equivalent or phosgene to an aprotic solvent, to form a compound of formula (I)
- wherein the phosgene synthetic equivalent is carbonyldiimidazole (CDI), diphosgene, triphosgene, a chloroformate or disuccinimidyl carbonate;
- and
- wherein the reaction is maintained at a temperature of no more than 30° C. and the reaction is carried out in the absence of a base.
8 more elements
Dependencies are inferred from the claim text.